{"id":"NCT02107196","sponsor":"Menarini Group","briefTitle":"12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)","officialTitle":"A 12-Week Double-blind, Randomised, Placebo-controlled, Parallel Group Phase III Study, Followed by a 4-Week Randomised Withdrawal Period to Evaluate the Efficacy and Safety of Oral Ibodutant 10 mg Once Daily in Female Patients With Irritable Bowel Syndrome With Diarrhea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-03","primaryCompletion":"2015-06","completion":"2015-06","firstPosted":"2014-04-08","resultsPosted":"2016-09-27","lastUpdate":"2017-01-19"},"enrollment":535,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Irritable Bowel Syndrome With Diarrhea"],"interventions":[{"type":"DRUG","name":"Ibodutant 10 mg","otherNames":["Code: MEN 15596"]},{"type":"DRUG","name":"Placebo","otherNames":["Sugar pill"]}],"arms":[{"label":"Ibodutant 10 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of oral ibodutant 10 mg once daily as compared to placebo in women with IBS-D over a 12-week treatment period.","primaryOutcome":{"measure":"Weekly Response for Abdominal Pain Intensity AND Stool Consistency Over 12 Weeks of Treatment in at Least 50% of the Weeks of Treatment (6 Out of 12 Weeks).","timeFrame":"12 weeks","effectByArm":[{"arm":"Ibodutant 10 mg","deltaMin":35.7,"sd":null},{"arm":"Placebo","deltaMin":34.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":12,"exclusionCount":20},"locations":{"siteCount":127,"countries":["United States","Bulgaria","Czechia","France","Germany","Italy","Poland","Romania","Russia","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":271},"commonTop":["Urinary tract infections","Nasopharyngitis","Headache","Back Pain","Nausea"]}}